Radiation and immune drugs team up to fight tough cancers
NCT ID NCT03104439
Summary
This study is testing whether combining two immunotherapy drugs (nivolumab and ipilimumab) with targeted radiation can help control advanced colorectal or pancreatic cancer. The goal is to see if this three-part approach can help the body's own immune system better recognize and attack cancer cells. The trial is for adults whose cancer has progressed after standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.